We found that JP could inhibit the activation of peritoneal macrophages in MRL/lpr lupus mice by regulating the IRAK1-NF-κB signaling pathway to achieve a certain therapeutic effect on SLE. The gene discussed is IRAK1; the disease is systemic lupus erythematosus.